A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

"We thought interferon might cause the stem cells to be killed by the immune system. But we found the retrotransposons turned on just enough interferon to activate blood cell production," said Dr.

Endothelial cells are also likely to participate in activation, both by production of cellular fibronectin and via conversion of transforming growth factor (TGF)-beta from the latent to active ...